Phase II study of PKC-α antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer

Paul Ritch, Charles M. Rudin, Jacob David Bitran, Martin J. Edelman, Alex Makalinao, David Irwin, Rogerio Lilenbaum, Patrick Peterson, William J. John

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of PKC-α antisense oligonucleotide aprinocarsen in combination with gemcitabine and carboplatin in patients with advanced non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences